EGFR and cancer: Cytokines such as interleukin (IL)-6, tumor necrosis factor (TNF)-a, transforming growth factor (TGF)-ß, and epithelial growth factor receptor (EGFR) ligands control the immune and inflammatory milieu and also have direct effects on cancer cell growth and survival through the activation of various downstream effectors [14,33].